FINV
FINAL DECISION TRANSACTION PROCESSED BY IB
06/18/2026
Back to search
Official data from USPTO
V VISISURE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
06/19/2026
Trademark type
Combined
Nice classes
5, 10
Filing date
02/12/2025
Registration date
10/14/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/14/2025
Last transaction
06/19/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
25
Owner location
CH
Examiner
LEASER, ANDREW C
Law office
M80
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the word "VISISURE" in light blue to the right of a dark blue stylized check mark formed by an outline of the letter V.
Holders and representatives
Holders
Novartis AG
Representatives
Maury M. Tepper, III Tepper & Eyster
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune systemthe metabolic systemthe endocrine systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Class 10
Medical injection devices sold empty
Publications
History of USPTO decisions and trademark events.
29 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/24/2026
FIMP
FINAL DISPOSITION PROCESSED
04/24/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/14/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/14/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
10/14/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/26/2025
PUBO
PUBLISHED FOR OPPOSITION
08/26/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/20/2025
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/05/2025
RFNT
REFUSAL PROCESSED BY IB
07/19/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/07/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/07/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
06/22/2025
RFRR
REFUSAL PROCESSED BY MPU
06/21/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/20/2025
CNRT
NON-FINAL ACTION WRITTEN
04/19/2025
DOCK
ASSIGNED TO EXAMINER
04/19/2025
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
04/04/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
04/04/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
04/04/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/04/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/04/2025
MAFR
APPLICATION FILING RECEIPT MAILED
03/31/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/31/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
03/28/2025
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
03/27/2025
Continuous trademark protection
Get notified about every new filing that threatens V VISISURE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.